2-61188143-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014709.4(USP34):c.10600G>A(p.Val3534Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,613,782 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014709.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP34 | ENST00000398571.7 | c.10600G>A | p.Val3534Ile | missense_variant | Exon 80 of 80 | 5 | NM_014709.4 | ENSP00000381577.2 | ||
AHSA2P | ENST00000394457.7 | n.3514C>T | non_coding_transcript_exon_variant | Exon 6 of 6 | 1 | |||||
USP34 | ENST00000411912.5 | c.3628G>A | p.Val1210Ile | missense_variant | Exon 26 of 26 | 5 | ENSP00000398960.1 | |||
USP34 | ENST00000436269.1 | c.1234G>A | p.Val412Ile | missense_variant | Exon 7 of 7 | 5 | ENSP00000398489.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000443 AC: 11AN: 248148Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134598
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461556Hom.: 2 Cov.: 30 AF XY: 0.0000234 AC XY: 17AN XY: 727050
GnomAD4 genome AF: 0.000131 AC: 20AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.10600G>A (p.V3534I) alteration is located in exon 80 (coding exon 80) of the USP34 gene. This alteration results from a G to A substitution at nucleotide position 10600, causing the valine (V) at amino acid position 3534 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at